Federal Bill Aims to Speed OTC Birth Control Efforts

May 17, 2016

In terms of costs, the National Center for Policy Analysis has argued that transitioning birth control to OTC would lower prices precipitously and result in dramatic savings, similarly to when proton pump inhibitors made the jump from prescription-only to OTC. Additionally, estimates from the Consumer Healthcare Products Association suggest that consumers save between $6 and $7 in prescription costs in unnecessary physician visits for every $1 spent on an OTC product.